Literature DB >> 22505422

Crystallization and preliminary X-ray diffraction analysis of human endoplasmic reticulum aminopeptidase 2.

David B Ascher1, Galina Polekhina, Michael W Parker.   

Abstract

Endoplasmic reticulum aminopeptidase 2 (ERAP2) is a critical enzyme involved in the final processing of MHC class I antigens. Peptide trimming by ERAP2 and the other members of the oxytocinase subfamily is essential to customize longer precursor peptides in order to fit them to the correct length required for presentation on major histocompatibility complex class I molecules. While recent structures of ERAP1 have provided an understanding of the `molecular-ruler' mechanism of substrate selection, little is known about the complementary activities of its homologue ERAP2 despite their sharing 49% sequence identity. In order to gain insights into the structure-function relationship of the oxytocinase subfamily, and in particular ERAP2, the luminal region of human ERAP2 has been crystallized in the presence of the inhibitor bestatin. The crystals belonged to an orthorhombic space group and diffracted anisotropically to 3.3 Å resolution in the best direction on an in-house X-ray source. A molecular-replacement solution suggested that the enzyme has adopted the closed state as has been observed in other inhibitor-bound aminopeptidase structures.
© 2012 International Union of Crystallography. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22505422      PMCID: PMC3325822          DOI: 10.1107/S1744309112006963

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  27 in total

1.  ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum.

Authors:  Thomas Serwold; Federico Gonzalez; Jennifer Kim; Richard Jacob; Nilabh Shastri
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

2.  Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues.

Authors:  Doriana Fruci; Patrizio Giacomini; Maria R Nicotra; Matteo Forloni; Rocco Fraioli; Loredana Saveanu; Peter van Endert; Pier Giorgio Natali
Journal:  J Cell Physiol       Date:  2008-09       Impact factor: 6.384

3.  Some crystal forms of bovine chymotrypsinogen B and chymotrypsinogen A.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

4.  The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues.

Authors:  Ian A York; Shih-Chung Chang; Tomo Saric; Jennifer A Keys; Janice M Favreau; Alfred L Goldberg; Kenneth L Rock
Journal:  Nat Immunol       Date:  2002-11-18       Impact factor: 25.606

5.  Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum.

Authors:  Loredana Saveanu; Oliver Carroll; Vivian Lindo; Margarita Del Val; Daniel Lopez; Yves Lepelletier; Fiona Greer; Lutz Schomburg; Doriana Fruci; Gabriele Niedermann; Peter M van Endert
Journal:  Nat Immunol       Date:  2005-05-22       Impact factor: 25.606

6.  IRAP identifies an endosomal compartment required for MHC class I cross-presentation.

Authors:  Loredana Saveanu; Oliver Carroll; Mirjana Weimershaus; Pierre Guermonprez; Elke Firat; Vivian Lindo; Fiona Greer; Jean Davoust; Roland Kratzer; Susanna R Keller; Gabriele Niedermann; Peter van Endert
Journal:  Science       Date:  2009-06-04       Impact factor: 47.728

7.  Altered global gene expression in first trimester placentas of women destined to develop preeclampsia.

Authors:  S A Founds; Y P Conley; J F Lyons-Weiler; A Jeyabalan; W Allen Hogge; K P Conrad
Journal:  Placenta       Date:  2008-11-21       Impact factor: 3.481

8.  Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1.

Authors:  Tina T Nguyen; Shih-Chung Chang; Irini Evnouchidou; Ian A York; Christos Zikos; Kenneth L Rock; Alfred L Goldberg; Efstratios Stratikos; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2011-04-10       Impact factor: 15.369

9.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  3 in total

Review 1.  Genetic associations and functional characterization of M1 aminopeptidases and immune-mediated diseases.

Authors:  N Agrawal; M A Brown
Journal:  Genes Immun       Date:  2014-08-21       Impact factor: 2.676

Review 2.  Antigenic peptide trimming by ER aminopeptidases--insights from structural studies.

Authors:  Efstratios Stratikos; Lawrence J Stern
Journal:  Mol Immunol       Date:  2013-03-29       Impact factor: 4.407

3.  Can ERAP1 and ERAP2 Form Functional Heterodimers? A Structural Dynamics Investigation.

Authors:  Athanasios Papakyriakou; Anastasia Mpakali; Efstratios Stratikos
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.